Gynecologic Oncology · 2017 · 50 citations · 17 references
MedicineMedicinal ChemistryOncologyCancer PharmacologyGynecologic OncologyMolecular OncologyAntibody ConjugatesAntibody-drug ConjugatesAnticancer Prodrug DesignOvarian CancerTargeted Cancer TherapyAntibody-drug Conjugate TherapyHer2 ExpressionHer2 InhibitorsHer2 Receptor SignalingHer2 Receptor TargetingHer2 Targeting LigandsHuman Epidermal Growth Factor Receptor 2 (Her2) ExpressionHuman Epidermal Growth Factor Receptor 2-Targeted Therapy
17
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text
Medicine, Oncology, Pharmacology +14
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote, Claes G. Tropé, Frédéric Amant et al. · New England Journal of Medicine · 2010 · 2.5K citations · Full text
Michael A. Bookman, Kathleen M. Darcy, Daniel L. Clarke‐Pearson et al. · Journal of Clinical Oncology · 2003 · 613 citations
Medicine, Gynecology, Oncology +17